ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 727729 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 727729; 2) Community: the network communities that were significantly associated with the response to NSC 727729; 3) Molecule: the relationships between components within communities and NSC 727729; 4) MDR: the compounds that were significantly associated with the NSC 727729.

NSC Compound Enrichment Correlation
NSC 639186 Raltitrexed 0.000380874609232497 0.56477686
NSC 708446 Null 0.000380874609232497 0.59861837
NSC 760289 3-hydroxy-8,9-dimethoxy-isoindolo[2,1a]quinoxalin-6-(5H)-imino 0.00078227743523216 0.38079235
NSC 683555 Camptothecin Derivative 0.000931492155975089 0.66085711
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.000944238008110127 0.62369038
NSC 648114 ANTINEOPLASTIC-D648114 0.000944238008110127 0.66332778
NSC 666571 7.alpha.-Methyl-3,11.beta.,17.beta.-trihydroxy estra-1,3,5(10)triene 11-nitrate ester 0.000944238008110127 0.25323968
NSC 671107 Null 0.000944238008110127 0.21618148
NSC 693543 4-Acridinecarboxamide, 9-amino-N-[3-[(2-aminoethyl)amino]propyl]-5-methyl-, trihydrochloride 0.000944238008110127 0.46571591
NSC 728316 6-(3-Piperazinyl-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-met hylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.00103112124545269 0.68092071
Total:58  Current:2    [First] [Prev] [Next] [Last]